LKFT Overview

Company Profile

Related stocks

LKFT.AS • Belgium

LAKEFRONT BIOTHERAPEUTICS

26.32 EUR

1.93B USD 1Y -13.7%

NAMS • Netherlands

NewAmsterdam Pharma Company N.V

21.58 USD

2.58B USD 1Y -35.3%

PHIL.MI • Italy

PHILOGEN

22 EUR

991.8M USD 1Y -5.4%

TUB.BR • Belgium

TUBIZE-FIN

170 EUR

8.48B USD 1Y -27%

PHM.MC • Spain

PHARMA MAR, S.A.

69.45 EUR

1.34B USD 1Y -21.3%

ZEAL.CO • Denmark

Zealand Pharma A/S

238 DKK

2.37B USD 1Y -53.5%

PHARM.AS • Netherlands

PHARMING GROUP

0.88 EUR

695.09M USD 1Y -32.1%

BSLN.SW • Switzerland

BASILEA N

65.5 CHF

977.91M USD 1Y +30.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

32.6% p.a.

Max Drawdown (5Y)

-68.3%

Sharpe Ratio (5Y)

-0.38

Beta Factor

0.06

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.6% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -91.7% in the extended horizon.